STOCK TITAN

Teladoc Health Names Laizer Kornwasser as President, Enterprise Growth & Global Markets

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

Teladoc Health (NYSE: TDOC) has appointed Laizer Kornwasser as President of Enterprise Growth and Global Markets, effective October 24, 2022. Kornwasser will focus on enhancing revenue and profit from the company's whole-person care strategy across various client channels, including US Group Health and BetterHelp. With over 20 years in healthcare, he previously led CareCentrix and held positions at Medco. CEO Jason Gorevic highlighted Kornwasser's expertise in driving growth and managing teams as vital for strengthening Teladoc's market position.

Positive
  • Appointment of Laizer Kornwasser as President indicates a strategic move to enhance revenue.
  • Kornwasser brings over 20 years of experience in healthcare, likely benefiting Teladoc's growth.
  • Focus on optimizing performance across multiple market channels could lead to increased profitability.
Negative
  • None.

PURCHASE, NY, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, has named Laizer Kornwasser as president, enterprise growth and global markets. In this role, Kornwasser is charged with further unlocking the revenue and profit growth potential of the company’s whole person care strategy across all client channels and product lines, reporting directly to Teladoc Health CEO Jason Gorevic as a member of his executive team.

Kornwasser’s role will take primary responsibility for optimizing company performance across Teladoc Health’s four market channels: US Group Health, International, Hospitals and Health Systems, and BetterHelp. For two decades Kornwasser has led business transformation and been at the forefront of operational excellence for diverse, high growth health care companies. 

“Laizer brings to Teladoc Health a wealth of proven experience and knowledge in health care, and we are excited to welcome him to the team,” said Gorevic. “From CareCentrix to Medco, Laizer has accelerated growth and managed mission-driven teams to bring innovative care to global clients and consumers alike. He will help us further capitalize on the cross-market and cross-product client opportunities that are at the core of making whole person care a reality.”

Kornwasser joins Teladoc Health from CareCentrix, where he served as president and chief operating officer, and was responsible for driving operational excellence and business strategy. Prior to that, Kornwasser held leadership roles at health care companies including Medco Health Solutions. He is also a professor at his alma mater, Yeshiva University. 

“Teladoc Health is already the global leader in whole person virtual care, and I am excited to help build on that foundation, further growing the commercial business and strengthening our solutions to capitalize on the emerging growth opportunities,” said Kornwasser.

Kornwasser starts his new role effective October 24, 2022. 

About Teladoc Health 
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Teladoc Health leverages more than two decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com or follow @TeladocHealth on Twitter. 

Source: Teladoc Health, Inc. – General 

Media: 
Carolyn Edwards 
321-795-1952 
pr@teladochealth.com


FAQ

Who is Laizer Kornwasser at Teladoc Health?

Laizer Kornwasser is the newly appointed President of Enterprise Growth and Global Markets, effective October 24, 2022.

What role will Kornwasser play at Teladoc Health?

He will optimize performance across Teladoc's four market channels and drive revenue growth.

What is the significance of Kornwasser's experience for Teladoc Health?

Kornwasser's extensive experience in healthcare is expected to positively impact Teladoc's growth strategies.

When did Laizer Kornwasser start his role at Teladoc Health?

Kornwasser officially started his role on October 24, 2022.

How can Kornwasser's appointment affect Teladoc's stock (TDOC)?

His appointment may enhance investor confidence and potentially lead to improved financial performance, positively influencing TDOC stock.

Teladoc Health, Inc.

NYSE:TDOC

TDOC Rankings

TDOC Latest News

TDOC Stock Data

1.54B
168.52M
0.81%
77.22%
14.92%
Health Information Services
Services-offices & Clinics of Doctors of Medicine
Link
United States of America
PURCHASE